Cynthia A. Moylan

5.3k total citations · 1 hit paper
75 papers, 3.6k citations indexed

About

Cynthia A. Moylan is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Cynthia A. Moylan has authored 75 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Epidemiology, 38 papers in Hepatology and 19 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Cynthia A. Moylan's work include Liver Disease Diagnosis and Treatment (56 papers), Liver Disease and Transplantation (20 papers) and Diet, Metabolism, and Disease (19 papers). Cynthia A. Moylan is often cited by papers focused on Liver Disease Diagnosis and Treatment (56 papers), Liver Disease and Transplantation (20 papers) and Diet, Metabolism, and Disease (19 papers). Cynthia A. Moylan collaborates with scholars based in United States, Canada and South Korea. Cynthia A. Moylan's co-authors include Anna Mae Diehl, Manal F. Abdelmalek, Cynthia D. Guy, Steve S. Choi, Todd I. Herrenkohl, Emiko A. Tajima, Roy C. Herrenkohl, Cindy Sousa, Gregory A. Michelotti and Mustafa R. Bashir and has published in prestigious journals such as The Lancet, JAMA and Journal of Biological Chemistry.

In The Last Decade

Cynthia A. Moylan

69 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

2019 536 citations Mustafa R. Bashir, Cynthia D. Guy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cynthia A. Moylan United States	26	2.2k	1.4k	919	751	688	75	3.6k
Diana Hull United Kingdom	15	1.8k 0.8×	647 0.5×	633 0.7×	1.4k 1.9×	511 0.7×	43	2.8k
Yock Young Dan Singapore	31	1.7k 0.8×	1.5k 1.1×	976 1.1×	569 0.8×	887 1.3×	111	3.7k
Chien‐An Sun Taiwan	33	2.6k 1.2×	1.7k 1.2×	703 0.8×	253 0.3×	437 0.6×	146	4.3k
Chung‐Pin Li Taiwan	35	1.0k 0.5×	740 0.5×	997 1.1×	82 0.1×	856 1.2×	170	4.5k
Preet Paul Singh United States	18	573 0.3×	337 0.2×	749 0.8×	242 0.3×	725 1.1×	42	2.9k
Virginia Clark United States	20	742 0.3×	643 0.5×	141 0.2×	191 0.3×	349 0.5×	57	1.4k
Abha G. Singh United States	14	663 0.3×	270 0.2×	414 0.5×	209 0.3×	514 0.7×	29	2.5k
Rey‐Heng Hu Taiwan	31	910 0.4×	1.5k 1.1×	639 0.7×	61 0.1×	1.4k 2.0×	213	3.5k
Noelle K. LoConte United States	25	497 0.2×	186 0.1×	478 0.5×	39 0.1×	771 1.1×	130	3.4k

Countries citing papers authored by Cynthia A. Moylan

Since Specialization

Citations

This map shows the geographic impact of Cynthia A. Moylan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia A. Moylan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia A. Moylan more than expected).

Fields of papers citing papers by Cynthia A. Moylan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cynthia A. Moylan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia A. Moylan. The network helps show where Cynthia A. Moylan may publish in the future.

Co-authorship network of co-authors of Cynthia A. Moylan

This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia A. Moylan. A scholar is included among the top collaborators of Cynthia A. Moylan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia A. Moylan. Cynthia A. Moylan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ng, Wee Han, Yee Hui Yeo, Hyun‐Seok Kim, et al.. (2025). Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction–associated steatotic liver diseases: Target trial emulation using real-world data. Hepatology. 83(2). 333–343. 5 indexed citations

Wegermann, Kara, Fouad Chouairi, Georgia Sofia Karachaliou, et al.. (2025). Incident Heart Failure is Common and Underrecognized in Patients with Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease. European Journal of Heart Failure. 27(11). 2041–2048. 1 indexed citations

Moylan, Cynthia A., et al.. (2024). Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease. 4(2). 5 indexed citations

Wegermann, Kara, Anna Mae Diehl, & Cynthia A. Moylan. (2023). Challenges and barriers in hepatocellular carcinoma (HCC) surveillance for patients with non-alcoholic fatty liver disease (NAFLD). Hepatoma Research. 9. 11–11. 3 indexed citations

Wegermann, Kara, Marat Fudim, Ricardo Henao, et al.. (2023). Serum Metabolites Are Associated With HFpEF in Biopsy‐Proven Nonalcoholic Fatty Liver Disease. Journal of the American Heart Association. 12(14). e029873–e029873. 5 indexed citations

Bowlus, Christopher L., Bertus Eksteen, Angela Cheung, et al.. (2023). Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology Communications. 7(6). 22 indexed citations

Alexopoulos, Anastasia‐Stefania, Alice Parish, Maren K. Olsen, et al.. (2023). Prescribing of evidence-based diabetes pharmacotherapy in patients with metabolic dysfunction-associated steatohepatitis. BMJ Open Diabetes Research & Care. 11(6). e003763–e003763. 3 indexed citations

Jou, Janice H., et al.. (2023). Updates in nonalcoholic fatty liver disease. Clinical Liver Disease. 22(5). 157–161.

Vidal, Adriana C., Yukun Liu, Susan K. Murphy, et al.. (2023). AHRR Hypomethylation mediates the association between maternal smoking and metabolic profiles in children. Hepatology Communications. 7(10). 2 indexed citations

10.

Vidal, Adriana C., Cynthia A. Moylan, Julius Wilder, et al.. (2022). Racial disparities in liver cancer: Evidence for a role of environmental contaminants and the epigenome. Frontiers in Oncology. 12. 959852–959852. 7 indexed citations

11.

Chung, Sunny, Matthew Phelan, Benjamin A. Goldstein, et al.. (2021). S1224 Computable Phenotypes for NAFLD and NASH Identify Patients with Significant Comorbidities yet Most Remain Undiagnosed. The American Journal of Gastroenterology. 116(1). S564–S564.

12.

Peters, Anthony E., Ambarish Pandey, Colby Ayers, et al.. (2021). Association of Liver Fibrosis Risk Scores with Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Findings from TOPCAT. ESC Heart Failure. 8(2). 842–848. 41 indexed citations

13.

Alexopoulos, Anastasia‐Stefania, Matthew J. Crowley, Ying Wang, et al.. (2021). Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease. Hepatology. 74(3). 1220–1233. 87 indexed citations

14.

Alexopoulos, Anastasia‐Stefania, et al.. (2021). Underrecognition of Nonalcoholic Fatty Liver Disease in Poorly Controlled Diabetes: A Call to Action in Diabetes Care. Journal of the Endocrine Society. 5(12). bvab155–bvab155. 10 indexed citations

15.

Henson, Jacqueline B., Julius Wilder, Matthew R. Kappus, et al.. (2020). Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C. Transplantation. 104(6). e164–e173. 9 indexed citations

16.

Du, Kuo, Satish K. Chitneni, Ayako Suzuki, et al.. (2019). Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression. Cellular and Molecular Gastroenterology and Hepatology. 10(1). 1–21. 77 indexed citations

17.

Machado, Mariana Verdelho, Leandi Krüger, Mark L. Jewell, et al.. (2015). Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model. Digestive Diseases and Sciences. 61(1). 137–148. 18 indexed citations

18.

Michelotti, Gregory, Marzena Swiderska‐Syn, Mariana Verdelho Machado, et al.. (2015). Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches. Gut. 65(4). 683–692. 27 indexed citations

19.

Choi, Steve S., Wing‐Kin Syn, Gamze Karaca, et al.. (2010). Leptin Promotes the Myofibroblastic Phenotype in Hepatic Stellate Cells by Activating the Hedgehog Pathway. Journal of Biological Chemistry. 285(47). 36551–36560. 136 indexed citations

20.

Morpeth, Susan C., John A. Crump, Habib O. Ramadhani, et al.. (2007). Predicting CD4 Lymphocyte Count <200 Cells/mm ³ in an HIV Type 1-Infected African Population. AIDS Research and Human Retroviruses. 23(10). 1230–1236. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact